Food and Drug Administration Safety Act of 2005

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeiting Drug Prevention Act, pharmaceutical counterfeiting HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

H.R. 3428 OTC Medicine Tax Fairness Act of 2005 S. 1514 OTC Medicine Tax Fairness Act of 2005 S. 3807 To amend the Federal Food, Drug and Cosmetic Act to provide for the regulation of all contact lenses as medical devices,and for other purposes H.R. 371 To amend the Federal Food, Drug and Cosmetic Act to provide for the regulation of all contaact lenses as medical devices, and for other purposes H.R. 5280 Distribution Act of 2006 H.R. 6111 Tax Relief and health Care Act (Medicare) S.3678 Pandemic All Hazards Preparedness Act (Biodefense) S.103 Combat Meth Act of 2005 H.R. 314 Combat Meth Act of 2005 S.950 Elimination of Neglected Diseases Act of 2005 H.R. 3057 Dept. of State, Foreign Operations, and Related Programs Appropriations Act, 2006 H.R. 2744 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2006 Federal Food, Drug and Cosmetic Act (Section 767) H.R. 5762 Contact Lens Consumer Protection Act H.R. 5337 National Security Foreign Investment Reform and Strengthened Transparency Act of 2006 Access to Life Saving Medicines Act Citizens Petition Access to Generics Public Health Service Act Drug Importation Medicare Part B and Part D Sickle Cell Anemia Immunosuppressant Legislation Cancer Therapies Legislation Gene Therapy Direct to Consumer Advertising Medicare Prescription Drugs and Modernization Act Follow-on Biologics Patent Law Reform Authorized Generics Drug Safety Legislation 1-800 Contacts DoD Authorization Language H.R. 2218 Regulation of non corrective contact lens as medical devises S. 930 Food and Drug Administration Safety Act of 2005 H.R. 2090 Food and Drug Administration Improvement Act of 2005 S. 470 FACT Act

Client expense: $1,860,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

e) S. 109, "Pharmaceutical Market Access Act of 2005". f) S. 334, "Pharmaceutical Market Access & Drug Safety Act of 2005". g) Issues related to clinical trial data bank. h) S. 470, H.R. 3196, "Fair Access to Clinical Trials Act". i) H.R. 6257, "Access to Life-Saving Medicines Act". a) Issues related to Drug Safety, Generic Biologics & Drug Approvals, FDA User Fees. b) S.930, "Food & Drug Administration Act of 2005". c) H.R. 2090, "Food & Drug Administration Improvement Act of 2005". d) H.R. 700, "Pharmaceutical Market Access & Drug Safety Act of 2005" - Importation.

Client expense: $1,231,846 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S 470, S 930, S 3807 - prescription drugs safety; generic drugs; best buy drugs; contact lens prescription non-discrimination; prescription drugs affordability' S 2342, HR 752 - Medicare Part D; FDA drugs safety

Client expense: $269,784 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Education, Dept of, Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Highway Traffic Safety Administration (NHTSA), Natl Telecommunications & Information Administration (NTIA), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), SENATE

FDA, drug approval, generics biologics, importation, clinical trial, drug and safety, PDUFA, conflict of interest HR 2090, Food and Drug Administration Improvement Act of 2005 HR 6257, Access to Life-Saving Medicine Act S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation S.109/H.R.328, Pharmaceutical Market Access Act of 2005 S.334, Pharmaceutical Market and Drug Safety Act of 2005 S.930, Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Drug safety clinical trials importation issues; conflict of interest. PDUFA S 3802, To amend the Consolidated Omnibus Budget Reconciliation Act of 1985 to expand the county organized health insuring organizations authorized to enroll Medicaid beneficiaries. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005 S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 328, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $60,000

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC)

Bioshield reauthorization. S 1873 - Biodefense and Pandemic Vaccine and Drug Development Act of 2005. S 1437 - Bioterror and Pandemic Preparedness Protection Act. HR 5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 6257, Access to Life-Saving Medicine Act. S 4016, Access to Life-Saving Medicine Act. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006 Drug Safety, Clinical Trials, drug importation. HR 700/S 334 - Pharmaceutical Market Access and Drug Safety Act of 2005. S 109/HR 328 - Pharmaceutical Market Access Act of 2005. S 930 - Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

e) S. 109, "Pharmaceutical Market Access Act of 2005". f) S. 334, "Pharmaceutical Market Access & Drug Safety Act of 2005". g) Issues related to clinical trial data bank. h) S. 470, H.R. 3196, "Fair Access to Clinical Trials Act". i) H.R. 6257, "Access to Life-Saving Medicines Act". a) Issues related to Drug Safety, Generic Biologics & Drug Approvals, FDA User Fees. b) S.930, "Food & Drug Administration Act of 2005". c) H.R. 2090, "Food & Drug Administration Improvement Act of 2005". d) H.R. 700, "Pharmaceutical Market Access & Drug Safety Act of 2005" - Importation.

Client expense: $1,231,846 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Legislation regarding pandemic vaccine production: H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005. Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Legislation controlling access to precursor chemicals for meth production and/or combating meth: H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, H.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,

Client expense: $820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 3807, Enhancing Drug Safety and Innovation Act of 2006 HR 6257, Access to Life-Saving Medicine Act Drug Approval Issues, Drug Safety Issues, FDA Issues Clinical Trials Conflict of Interest, Follow-on Biologics, PDUFA IV Issues relating to generics, biotechnology, and drug reimportation H.R.700/S334 Pharmaceutical Market Access and Drug and Safety Act of 2005/S334 H.R.328/S109 Pharmaceutical Market Access Act of 2005 S930 Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

NIH Reform Act (HR 6164), Enhancing Drug Safety and Innovation Act (S.3807), SAFE Drug Act (HR 5922), Food and Drug Administration Safety Act (S 930)

Client expense: $15,790 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 3807 - Enhancing Drug Safety and Innovation Act of 2006 H.R. 1420 - Families for ED Advertising Decency Act H.R. 3696 - Medical Advertising Reform Act H.R. 3950 - Responsibility in Drug Advertising Act of 2005 H.R. 4429 - Food and Drug Administration Safety Act of 2005 Responded to GAO report on prescription drug advertising. Proposals to end, restrict, or limit the marketing of pharmaceutical products to consumers and physicians. S. 930 - Food and Drug Administration Safety Act of 2005 S. 1128 - Pharmaceutical Advertising and Prudent Purchasing Act

Client expense: $440,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

HR 554 Personal Responsibility in Food Consumption Act HR 575 Say No to Drug Ads Act HR 1145 Safe Rating Act HR 1420 Families for Advertising Decency Act HR 1655 America RX Act HR 4860 Childhood Obesity Reduction Act HR 5737 Children's Health Federal Trade Commission Authority Restoration S. 799 Prevention of Childhood Obesity Act S. 930 Food and Drug Administration Safety Act of 2005 S. 1074 HELP America Act S. 1128 Pharmaceutical Advertising and Prudent Purchasing Act S. 1324 Childhood Obesity Reduction Act S. 1325 IMPACT Act Oppose unconstitutional restrictions on advertisers' and publishers' commercial free speech on all lawful products, including such products as prescription medications, alcoholic beverages. Oppose restrictions on advertising lawful products to children. Oppose restrictions on media broadcasts. FTC actions regarding food advertising, including weight loss products. FTC review of violence on television FTC actions pertaining to unsolicited commercial e-mail or SPAM. FCC action regarding telemarketing. FCC actions regarding children's television, including digital television. Advertising and promotion of prescription medicines. Multicultural advertising. International advertising issues. Data privacy and advertising issues. HR 3950 Responsibility in Drug Advertising Act of 2005 HR 3696 Medical Advertising Reform Act HR 4124 CAMRA Act HR 4395 Pharmaceutical Market Access Act of 2005

Client expense: $120,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Fair Access to Clinical Trials Act (S470/HR3196); FDA Improvement Act (S930/HR2090); Wired for Health Care Quality Act (S1418); Pharmaceutical Market Access and Drug Safety Act (S109/S334/HR328/HR700); Labor-HHS Appropriations; AHRQ Comparative Effectiveness Research (HR 5975); Reauthorization of PDUFA; Health Information Technology (HR 4157/S 1418) FDA reform regarding oversight of drug safety.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug safety and importation issues, Clinical trials. Generics Biologics HR 328, Pharmaceuticals Market Access Act of 2005. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. S 109, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

1. S. 334, HR 700, S. 1551, S. 109, HR 2744-Specifically, provisions relating to the importation of prescription drugs. 2. S. 930-A bill to amend the Food and Drug Administration Safety Act, with respect to drug safety.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 109- Pharmaceutical Market Access Act of 2005; S. 184-Safe Import Act of 2005; H.R. 700, S. 334-Pharmaceutical Market Access and Drug Safety Act of 2005; and S. 930 Food & Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 575 Say No to Drug Ads Act; HR 1420 Families for Advertising Decency Act; HR 1655 America RX Act; S 930 Food & Drug Adminstration Safety Act; S 1074 HELP America Act; S 1128 Pharmaceutical Advertising and Prudent Purchasing Act; HR 3950 Responsibility in Drug Advertising Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, Lobbied for final passage of the bill. H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs.

Client expense: $2,980,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Medicare Prescription Drug and Modernization Act of 2003 S.930 - Food and Drug Administration Safety Act of 2005 H.Con.Res.376 - Concurrent Resolution on the Budget for Fiscal Year 2007 H.R.4157 - Health Information Technology Promotion Act of 2006 H.R.6048 - Medicare Outpatient Therapy Value-Based Purchasing Act of 2006 Implementation of DRA (Deficit Reduction Act)

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Medicare Prescription Drug and Modernization Act of 2003 S.930 - Food and Drug Administration Safety Act of 2005 H.Con.Res.376 - Concurrent Resolution on the Budget for Fiscal Year 2007 H.R.4157 - Health Information Technology Promotion Act of 2006 H.R.6048 - Medicare Outpatient Therapy Value-Based Purchasing Act of 2006 Implementation of DRA (Deficit Reduction Act)

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Drug importation, drug safety issues, clinical trials Conflict of Interest, PDUFA, Drug pricing S 2766, national Defense Authorization Act for Fiscal Year 2007; drug pricing. HR 2090, Food and Drug Administration Improvement Act of 2005 HR 328, Pharmaceutical Market Access Act of 2005. S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act HR 6257, Access to Life-Saving Medicine Act HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation. S 109, Pharmaceutical Market Access Act of 2005. S 334 Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $180,000

Government targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE

43. H.R. 1539, a bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug 44. S. 338, the Bipartisan Commission on Medicaid Act of 2005 45. H.R. 985, the Bipartisan Commission on Medicaid Act of 2005 46. S. Con.Res.18, Budget FY2006 Appropriations resolution 47. H. Con.Res.95, 18, Budget FY2006 Appropriations resolution 48. S. 1262, the Health Technology to Enhance Quality Act of 2005 49. S.3678, the Pandemic and All-Hazards Preparedness Act 50. S.2564, the Biodefense and Pandemic Vaccine and Drug Development Act of 2006 51. H.R. 5533, the Biodefense and Pandemic Vaccine and Drug Development Act 52. H.R. 5262, Tax Free Savings Act of 2006 53. S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act 54. H.R. 4157, the Health Information Technology Promotion Act of 2006 55. S. 2766, the National Defense Authorization Act for Fiscal Year 2007 56. H.R.5122, the National Defense Authorization Act for Fiscal Year 2007 57. S.2810, the Medicare Late Enrollment Assistance Act of 2006 58. H.R.5399, the Medicare Drug Benefit Enrollment Fairness Act of 2006 59. H.R. 5182, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 60. S. 2563, the Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 61. S. 2664, the Pharmacy Access Improvement (PhAIm) Act of 2006 62. H.R. 4769, the Prescription Drug Elimination Act of 2006 63. S. 2300, the Lower Prices With Increased Competition and Efficient Development of Drugs Act (the Lower Priced Drugs Act) 64. H.R. 5166 – The Independent Pharmacy Protection Act of 2006 65. S. 2181, the Medicare State Reimbursement Act 66. S. 2183, the Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act 67. H.R. 4297, the Tax Relief Extension Reconciliation Act 68. H.R. 5384, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 69. H.R.5441, the Department of Homeland Security Appropriations Act, 2007 70. S. 2020, Tax Relief Act of 2005 71. HR 5122 - FY2007 National Defense Authorization Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 72. HR 5182 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 73. S. 2563 - Pharmacist Access and Recognition in Medicare (PHARM) Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 74. S. 1932 - Deficit Reduction Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 1. H.R. 4241, the Deficit Reduction Act of 2005 2. S. 1932, the Senate Deficit Reduction Act of 2005 3. H.R. 6111, the Tax Relief and Health Care Act of 2006 4. H.R. 5280, the Dextromethorphan Distribution Act of 2006 5. S.3807. the Enhancing Drug Safety and Innovation Act of 2006 6. H.R. 6257, the Access to Life-Saving Medicine Act 7. H.R. 5970, the Estate Tax and Extension of Tax Relief Act of 2006 8. S. 1716, Emergency Health Care Relief Act of 2005 9. H.R. 4297, the Tax Relief Extension Reconciliation Act 10. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 11. S. 544, the Patient Safety and Quality Improvement Act of 2005 12. H.R. 3205, the Patient Safety and Quality Improvement Act of 2005 13. H.R. 1132, the National All Schedules Prescription Electronic Reporting Act of 2005 14. S. 518, the National All Schedules Prescription Electronic Reporting Act of 2005 15. S. 1392, the Federal Trade Commission Reauthorization Act of 2005 16. S. 334, the Pharmaceutical Market Access and Drug Safety Act 17. H.R. 700, the Pharmaceutical Market Access and Drug Safety Act of 2005 18. S. 309, the Pharmaceutical Market Access Act 19. H.R. 328, the Pharmaceutical Market Access Act 20. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 21. H.R. 1808, the Safe Online Drug Act of 2005 22. S. 399, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 23. H.R. 840, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 24. S. 14, the Fair Wage, Competition, and Investment Act of 2005 25. S. 534, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 26. H.R. 5, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 27. H.R. 1669, the Pharmacy Benefit Manager Transparency Act of 2005 28. H.R. 1671, the Community Pharmacy Fairness Act of 2005 29. S. 103, the Combat Meth Act of 2005 30. H.R. 314, the Combat Meth Act of 2005 31. S. 102, the Exile Meth Act 32. H.R. 313, the Exile Meth Act 33. H.R. 3889, Meth Epidemic Elimination Act 34. H.R. 1378, the Ephedrine Alkaloids Regulation Act of 2005 35. H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005 36. H.R. 3617, the Medicare Value-Based Purchasing for Physicians' Services Act of 2005 37. S. 1356, the Medicare Value Purchasing Act of 2005 38. S. 1408, the Identity Theft Protection Act 39. S. 1332, the Personal Data Privacy and Security Act of 2005 40. S. 930, the Food and Drug Administration Safety Act of 2005 41. H.R. 1652, the Access to Legal Pharmaceuticals Act 42. S. 809, the Access to Legal Pharmaceuticals Act See addendum

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, White House Office

Implementation of Medicare Prescription Drug and Modernization Act of 2003 S.930 - Food and Drug Administration Safety Act of 2005 H.Con.Res.376 - Concurrent Resolution on the Budget for Fiscal Year 2007 H.R.4157 - Health Information Technology Promotion Act of 2006 H.R.6048 - Medicare Outpatient Therapy Value-Based Purchasing Act of 2006 Implementation of DRA (Deficit Reduction Act)

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Medicare Prescription Drug and Modernization Act of 2003 S.930 - Food and Drug Administration Safety Act of 2005 H.Con.Res.376 - Concurrent Resolution on the Budget for Fiscal Year 2007 H.R.4157 - Health Information Technology Promotion Act of 2006 H.R.6048 - Medicare Outpatient Therapy Value-Based Purchasing Act of 2006 Implementation of DRA (Deficit Reduction Act)

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Medicare Prescription Drug and Modernization Act of 2003 S.930 - Food and Drug Administration Safety Act of 2005 H.Con.Res.376 - Concurrent Resolution on the Budget for Fiscal Year 2007 H.R.4157 - Health Information Technology Promotion Act of 2006 H.R.6048 - Medicare Outpatient Therapy Value-Based Purchasing Act of 2006 Implementation of DRA (Deficit Reduction Act)

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Implementation of Medicare Prescription Drug and Modernization Act of 2003 S.930 - Food and Drug Administration Safety Act of 2005 H.Con.Res.376 - Concurrent Resolution on the Budget for Fiscal Year 2007 H.R.4157 - Health Information Technology Promotion Act of 2006 H.R.6048 - Medicare Outpatient Therapy Value-Based Purchasing Act of 2006 Implementation of DRA (Deficit Reduction Act)

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 930, Food and Drug Administration Safety Act of 2005 HR 5384, Agriculture Appropriations

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2090, Food and Drug Administration Improvement Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. H.R.753, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. H.R.870, Pharmaceutical Research and Manufacturers Accountability Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.16, Affordable Health Care Act, Lobbied to prevent provisions adverse to prescription drug approval process. S.930, Food and Drug Administration Safety Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.184, Safe IMPORT Act of 2005, Lobbied to prevent unsafe importation of prescription drugs. S.470, FACT Act, Fair Access to Clinical Trials Act of 2005, Lobbied to prevent provisions adverse to prescription drug approval process. S.3650, The Helping to Fill the Medicare Rx Gap Act, lobbied for final passage of the bill.

Client expense: $2,760,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

1. H.R. 4241, House Deficit Reduction Act of 2005 2. S. 1932, Senate Deficit Reduction Act of 2005 3. H.R. 3199, USA Patriot Act Reauthorization 4. S. 1716, Emergency Health Care Relief Act of 2005 5. H.R. 4297, the Tax Relief Extension Reconciliation Act 6. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 7. S. 544, the Patient Safety and Quality Improvement Act of 2005 8. H.R. 3205, the Patient Safety and Quality Improvement Act of 2005 9. H.R. 1132, the National All Schedules Prescription Electronic Reporting Act of 2005 10. S. 518, the National All Schedules Prescription Electronic Reporting Act of 2005 11. S. 1392, the Federal Trade Commission Reauthorization Act of 2005 12. S. 334, the Pharmaceutical Market Access and Drug Safety Act 13. H.R. 700, the Pharmaceutical Market Access and Drug Safety Act of 2005 14. S. 309, the Pharmaceutical Market Access Act 15. H.R. 328, the Pharmaceutical Market Access Act 16. S.3, the Protecting America in the War on Terror Act of 2005 17. H.R. 3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 18. H.R. 1808, the Safe Online Drug Act of 2005 19. S. 399, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 20. H.R. 840, the Ryan Haight Internet Pharmacy Consumer Protection Act of 2005 21. S. 14, the Fair Wage, Competition, and Investment Act of 2005 22. S. 534, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 23. H.R. 5, the Health Efficient, Accessible, Low-Cost, Timely Healthcare Act of 2005 24. H.R. 1669, the Pharmacy Benefit Manager Transparency Act of 2005 25. H.R. 1671, the Community Pharmacy Fairness Act of 2005 26. S. 103, the Combat Meth Act of 2005 27. H.R. 314, the Combat Meth Act of 2005 28. S. 102, the Exile Meth Act 29. H.R. 313, the Exile Meth Act 30. H.R. 3889, Meth Epidemic Elimination Act 31. H.R. 1446, the Methamphetamine Abuse Prevention Act of 2005 32. H.R. 1055, the Comprehensive Methamphetamine Response Act 33. H.R. 1056, the Methamphetamine Precursor Control Act of 2005 34. H.R. 1378, the Ephedrine Alkaloids Regulation Act of 2005 35. H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005 36. H.R. 3617, the Medicare Value-Based Purchasing for Physicians' Services Act of 2005 37. S. 1356, the Medicare Value Purchasing Act of 2005 38. S. 1408, the Identity Theft Protection Act 39. S. 1332, the Personal Data Privacy and Security Act of 2005 40. S. 930, the Food and Drug Administration Safety Act of 2005 41. H.R. 1652, the Access to Legal Pharmaceuticals Act 42. S. 809, the Access to Legal Pharmaceuticals Act 43. H.R. 1539, a bill to amend the Public Health Service Act with respect to the responsibilities of a pharmacy when a pharmacist employed by the pharmacy refuses to fill a valid prescription for a drug 44. S. 338, the Bipartisan Commission on Medicaid Act of 2005 45. H.R. 985, the Bipartisan Commission on Medicaid Act of 2005 46. S. Con.Res.18, Budget FY2006 Appropriations resolution 47. H. Con.Res.95, 18, Budget FY2006 Appropriations resolution 48. S. 1262, the Health Technology to Enhance Quality Act of 2005 49. S.3678, the Pandemic and All-Hazards Preparedness Act 50. S.2564, the Biodefense and Pandemic Vaccine and Drug Development Act of 2006 51. H.R. 5533, the Biodefense and Pandemic Vaccine and Drug Development Act 52. H.R. 5262, Tax Free Savings Act of 2006 53. S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act 54. H.R. 4157, the Health Information Technology Promotion Act of 2005 55. S. 2766, the National Defense Authorization Act for Fiscal Year 2007 56. S.2810, the Medicare Late Enrollment Assistance Act of 2006 57. H.R.5399, the Medicare Drug Benefit Enrollment Fairness Act of 2006 58. H.R. 5182, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 59. S. 2563, the Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 60. S. 2664, the Pharmacy Access Improvement (PhAIm) Act of 2006 61. H.R. 4769, the Prescription Drug Elimination Act of 2006 62. S. 2300, the Lower Prices With Increased Competition and Efficient Development of Drugs Act (the Lower Priced Drugs Act) 63. H.R. 5166 – The Independent Pharmacy Protection Act of 2006 64. S. 2181, the Medicare State Reimbursement Act 65. S. 2183, the Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act 66. H.R. 4297, the Tax Relief Extension Reconciliation Act 67. H.R. 5384, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 68. H.R.5441, the Department of Homeland Security Appropriations Act, 2007 69. S. 2020, Tax Relief Act of 2005

Client expense: $460,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE, White House Office

Wired for Health Care Quality Act (S1418) Pharmaceutical Market Access and Drug Safety Act (S109/S334/HR328/HR700) "Conscience Clause" legislation (HR1539) Pharmacy Benefit Manager Transparency Act (HR1669) Community Pharmacy Fairness Act (HR 1671) Patient Safety and Quality Improvement Act (S544/HR3205) Fair Access to Clinical Trials Act (S470/HR3196) National All Schedules Prescription Electronic Reporting Act (S518/HR1132) FDA Improvement Act (S930/HR2090)

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 575 Say No to Drug Ads Act H.R. 1420 Families for ED Advertising Decency Act H.R. 1655 America Rx Act of 2005 H.R. 3950 Responsibility in Drug Advertising Act of 2005 H.R. 3696 Medical Advertising Reform Act H.R. 2090 Food and Drug Administration Improvement Act of 2005 H.R. 4429 Food and Drug Administration Safety Act of 2005 S. 1128 Pharmaceutical Advertising and Prudent Purchasing Act S. 930 Food and Drug Administration Safety Act of 2005 S. 1932 Deficit Reduction Omnibus Reconciliation Act of 2005 H.R. 554 Personal Responsibility in Food Consumption Act H.R. 4124 CAMRA Act S. 1074 HELP America Act S. 799 Prevention of Childhood Obesity Act S. 1325 IMPACT Act S. 1324 Childhood Obesity Reduction Act S. 579 CAMRA Act S. 908 Commonsense Consumption Act of 2005 Oppose unconstitutional restrictions on advertisers' and publishers' commercial free speech on products such as Rx drugs, alcohol, also violence in the media, and children's advertising. FTC action regarding food advertising, including products and weight-loss FTC study of television violent content FTC action regarding SPAM FCC action regarding telemarketing, DO NOT CALL, DO NOT FAX FCC actions regarding advertising restriction on children's television Rx drug advertising and promotion Multicultural advertising issues International advertising issues Privacy and advertising issues

Client expense: $200,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Clinical trials; Katrina public health; S.544 & HR 3205 Patient safety; S.470 Fact Act; S.1418 Health Information Technology; S.930 Food and Drug Administration Safety Act

Client expense: $278,948 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of the Comptroller of the Currency (OCC), SENATE, State, Dept of (DOS)